MedPath

Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

Not yet recruiting
Conditions
Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Interventions
Drug: Chemotherapy
Registration Number
NCT06535334
Lead Sponsor
Far Eastern Memorial Hospital
Brief Summary

This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy
Exclusion Criteria
  • women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
intravenous chemotherapyChemotherapytriweekly chemotherapy with carboplatin AUC=5\~6 + liposomal-doxorubicin 30\~40mg/m2 or paclitaxel 175mg/m2 0r docetaxel 60\~75mg/m2
intraperitoneal chemotherapyChemotherapyDay 1 IV Paclitaxel 135 mg/m2 + IP Cisplatin 75-100 mg/m2 or IP carboplatin (AUC = 6) Day 8 IP Paclitaxel 60 mg/m2 Every 21 days \* 6 cycles OR Day 1 IP Carboplatin AUC=5 or IP Cisplatin 50-75mg/m2 Day 2 IV Liposomal doxorubicin 15 mg/m2 + IP Liposomal doxorubicin 15 mg/m2 Every 28 days \* 6 cycles
Primary Outcome Measures
NameTimeMethod
RFSthe time interval from the date of surgery or the start of chemotherapy to clinically defined recurrence, disease progression, death from any cause or last follow-up

Recurrence free survival

OSthe time interval from the date of surgery or the start of chemotherapy to the date of death from any cause or last follow-up

Overall Survival

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital

🇨🇳

Banqiao, New Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath